Cargando…
Olaparib significantly delays photoreceptor loss in a model for hereditary retinal degeneration
The enzyme poly-ADP-ribose-polymerase (PARP) mediates DNA-repair and rearrangements of the nuclear chromatin. Generally, PARP activity is thought to promote cell survival and in recent years a number of PARP inhibitors have been clinically developed for cancer treatment. Paradoxically, PARP activity...
Autores principales: | Sahaboglu, Ayse, Barth, Melanie, Secer, Enver, Amo, Eva M. del, Urtti, Arto, Arsenijevic, Yvan, Zrenner, Eberhart, Paquet-Durand, François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5177898/ https://www.ncbi.nlm.nih.gov/pubmed/28004814 http://dx.doi.org/10.1038/srep39537 |
Ejemplares similares
-
Temporal progression of PARP activity in the Prph2 mutant rd2 mouse: Neuroprotective effects of the PARP inhibitor PJ34
por: Sahaboglu, Ayse, et al.
Publicado: (2017) -
Poly ADP ribosylation and extracellular vesicle activity in rod photoreceptor degeneration
por: Vidal-Gil, Lorena, et al.
Publicado: (2019) -
Identification of a Common Non-Apoptotic Cell Death Mechanism in Hereditary Retinal Degeneration
por: Arango-Gonzalez, Blanca, et al.
Publicado: (2014) -
Calpain and PARP Activation during Photoreceptor Cell Death in P23H and S334ter Rhodopsin Mutant Rats
por: Kaur, Jasvir, et al.
Publicado: (2011) -
PARP1 Gene Knock-Out Increases Resistance to Retinal Degeneration without Affecting Retinal Function
por: Sahaboglu, Ayse, et al.
Publicado: (2010)